Abstract |
Treating patients known to have immune thrombocytopenic purpura ( ITP) presenting with acute coronary syndrome (ACS) pose challenges, especially if they undergo percutaneous coronary intervention and stenting, as they require certain period of dual anti-platelet medication based up on the type of stent been deployed. Co-existence of therapies to increase platelet number as well as anti-platelet efficacy at the same time appears contradictory; imbalance in antagonistic treatment approach of increasing platelet number to treat ITP and inhibiting their activity to treat ACS can result in life threatening complications.
|
Authors | Ashish H Shah, Richard A Anderson, Ali Raza Khan, Timothy D Kinnaird |
Journal | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
(Hellenic J Cardiol)
(Aug 20 2016)
ISSN: 2241-5955 [Electronic] Netherlands |
PMID | 27639318
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Hellenic Cardiological Society. All rights reserved. |